| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |